Stability of the recombinant antierbB2 scFvFcinterleukin2 fusion protein and its inhibition of HER2overexpressing tumor cells

By                      

International Journal of Oncology, Vol. 42, Iss. 2, 2013-01 ,pp. : 507-516

Spandidos Publications

Access to resources Recommend Favorite

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

By Lipton Allan   Goodman Laurie   Leitzel Kim   Cook Jennifer   Sperinde Jeff   Haddad Mojgan   Köstler Wolfgang   Huang Weidong   Weidler Jodi   Ali Suhail   Newton Alicia   Fuchs Eva-Marie   Paquet Agnes   Singer Christian   Horvat Reinhard   Jin Xueguang   Banerjee Joyee   Mukherjee Ali   Tan Yuping   Shi Yining   Chenna Ahmed   Larson Jeff   Lie Yolanda   Sherwood Thomas   Petropoulos Christos   Williams Stephen   Winslow John   Parry Gordon   Bates Michael  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 43-53

Springer Publishing Company

Access to resources Recommend Favorite

Suppression of Diacylglycerol Levels by Antibodies Reactive with the c-erbB-2 (HER-2/neu) Gene Product p185 c-erbB-2 in Breast and Ovarian Cancer Cell Lines

By Boente M.P.   Berchuck A.   Whitaker R.S.   Kalen A.   Xu F.-J.   Clarke-Pearson D.L.   Bell R.M.   Bast R.C.  

Gynecologic Oncology, Vol. 70, Iss. 1, 1998-07 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite

α-eleostearic acid inhibits growth and induces apoptosis in breast cancer cells via HER2/HER3 signaling

By              

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 993-998

Spandidos Publications

Access to resources Recommend Favorite

Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian Cancer

By Ferrandina G.   Ranelletti F.O.   Lauriola L.   Fanfani F.   Legge F.   Mottolese M.   Nicotra M.R.   Natali P.G.   Zakut V.H.   Scambia G.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 305-310

Academic Press

Access to resources Recommend Favorite